TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21561497

Group type: EXPERIMENTAL
Intervention: Stepped smoking cessation intervention based on the transtheoretical model of change, involving 6-month implementation of recommendations from a Clinical Practice Guideline including brief motivational interviews, brief intervention, intensive intervention with pharmacotherapy, and reinforcing intervention.
Number of subjects: 2827

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 2827
Study: 19388915

Group type: EXPERIMENTAL
Intervention: Packing
Number of subjects: 48

Group type: COMPARATOR
Intervention: No Packing
Number of subjects: 48
Study: 16686908

Group type: EXPERIMENTAL
Intervention: Prophylaxis treatment for migraine
Number of subjects: 141
Study: 15462110

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dietary therapy alone
Number of subjects: 80
Study: 11208680

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8989010

Group type: EXPERIMENTAL
Intervention: 500 mL of hetastarch solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1000 mL of lactated Ringer's solution
Number of subjects: 40
Study: 7655330

Group type: EXPERIMENTAL
Intervention: 10 g/day ground flaxseed
Number of subjects: 13

Group type: COMPARATOR
Intervention: Usual diet (control)
Number of subjects: 13
Study: 2106401

Group type: EXPERIMENTAL
Intervention: Procainamide (750 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tocainide (600 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Encainide (50 mg)
Number of subjects: 21
Study: 346257

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg per day) for 7 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 67
Study: 30740221

Group type: EXPERIMENTAL
Intervention: Microbiology test ordering practices
Number of subjects: 1731

Group type: EXPERIMENTAL
Intervention: Microbiology test results
Number of subjects: 1731

Group type: EXPERIMENTAL
Intervention: Additional microbiology testing
Number of subjects: 1731
Study: 26696034

Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention delivered face to face by a specialized HF nurse, including viewing a DVD and verbal discussion supported by a written manual.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual education (control group).
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention.
Number of subjects: 200
Study: 26372383

Group type: EXPERIMENTAL
Intervention: tenofovir/emtricitabine along with atazanavir/ritonavir (ATV/r)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir (DRV/r)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: raltegravir (RAL)
Number of subjects: 328
Study: 24795227

Group type: EXPERIMENTAL
Intervention: User-friendly algorithm for anaphylaxis case definition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard case definition for anaphylaxis
Number of subjects: 40
Study: 21969227

Group type: EXPERIMENTAL
Intervention: Vorapaxar 40 mg single dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vorapaxar 2.5 mg daily maintenance dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vorapaxar (various doses: 5, 10, 20, or 40 mg single doses; 0.5, 1, or 2.5 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vorapaxar (various doses)
Number of subjects: 0
Study: 19852833

Group type: EXPERIMENTAL
Intervention: Haemoglobin (HB) target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Ferritin target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Iron target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Transferrin target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Transferrin saturation percentage (TSAT %) target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Haemodialysis KT/V target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis KT/V target maintenance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Erythropoietin dose
Number of subjects: 540
Study: 17443852

Group type: EXPERIMENTAL
Intervention: Synbiotics + neomycin + mechanical bowel preparation (MBP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Mechanical bowel preparation only
Number of subjects: 92

Group type: COMPARATOR
Intervention: Neomycin + mechanical bowel preparation (MBP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Synbiotics + neomycin without mechanical bowel preparation (MBP)
Number of subjects: 92
Study: 14995924

Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg daily for 10 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Promethazine 75 mg daily for 10 days
Number of subjects: 80
Study: 12000585

Group type: EXPERIMENTAL
Intervention: Assertive community treatment
Number of subjects: 0
Study: 9127395

Group type: EXPERIMENTAL
Intervention: AOO pacing (rate 80)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DOO pacing in the right ventricular apex (AV delay 100 ms)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DOO pacing in the right ventricular outflow tract
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DOO pacing at both right ventricular sites simultaneously
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sinus rhythm
Number of subjects: 11
Study: 8458042

Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 3540032

Group type: EXPERIMENTAL
Intervention: Ketorolac 5 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diflunisal 500 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 28413900

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) + medication
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) alone
Number of subjects: 88
Study: 30110009

Group type: EXPERIMENTAL
Intervention: Aroma therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Joint-therapy (aroma therapy + music intervention)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (regular post-surgical nursery)
Number of subjects: 100
Study: 28181167

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low-fat control group
Number of subjects: 36
Study: 25322165

Group type: COMPARATOR
Intervention: Oral terbinafine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Long-pulsed Nd:YAG laser treatment
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Combined treatment (Oral terbinafine + Long-pulsed Nd:YAG laser)
Number of subjects: 53
Study: 22301569

Group type: EXPERIMENTAL
Intervention: Vaginal irrigation with saline
Number of subjects: 109

Group type: COMPARATOR
Intervention: No irrigation (Control)
Number of subjects: 109
Study: 20142584

Group type: EXPERIMENTAL
Intervention: PSA screening in the United States
Number of subjects: 0

Group type: COMPARATOR
Intervention: PSA screening in ERSPC-Rotterdam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSA test sensitivity for nonpalpable local-or regional-stage cancers (stage T1M0) in the United States
Number of subjects: 0

Group type: COMPARATOR
Intervention: PSA test sensitivity for nonpalpable local-or regional-stage cancers (stage T1M0) in ERSPC-Rotterdam
Number of subjects: 0
Study: 17624052

Group type: EXPERIMENTAL
Intervention: Heparin-coated catheter with 50 mL/d of normal saline solution as a continuous infusion
Number of subjects: 246
Study: 16291713

Group type: EXPERIMENTAL
Intervention: Buccal administration of prochlorperazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buccal administration of prochlorperazine, twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral tablet of prochlorperazine
Number of subjects: 0
Study: 12780953

Group type: EXPERIMENTAL
Intervention: Nurse-led weaning (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Registrar-led weaning (n = 23)
Number of subjects: 50
Study: 10442380

Group type: EXPERIMENTAL
Intervention: UFT plus calcium folinate plus radiotherapy
Number of subjects: 0
Study: 7769597

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 1.0 mg (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal diamorphine 0.75 mg (n = 30)
Number of subjects: 60
Study: 1827709

Group type: EXPERIMENTAL
Intervention: Normoxic exercise (21% O2)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hypoxic exercise (13.3 +/‐ 0.3% O2)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Comparison between normoxic and hypoxic exercise
Number of subjects: 6
Study: 6456960

Group type: EXPERIMENTAL
Intervention: 6 week physical training program
Number of subjects: 50

Group type: COMPARATOR
Intervention: No supervised physical activity
Number of subjects: 50
Study: 30557279

Group type: EXPERIMENTAL
Intervention: Direct instruction
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Video instruction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Written-pictorial instruction
Number of subjects: 96
Study: 28610960

Group type: EXPERIMENTAL
Intervention: Noxious thermal stimulation (heat pain 46‐47°C/cold pain 7‐8°C)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Innocuous thermal stimulation (heat 40‐41°C/cold 20‐21°C)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups (Noxious and Innocuous TS)
Number of subjects: 79
Study: 25916658

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24129553

Group type: EXPERIMENTAL
Intervention: Pulsed orocutaneous stimulation during gavage feedings
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control condition (no stimulation)
Number of subjects: 22
Study: 22452758

Group type: EXPERIMENTAL
Intervention: Mindful self-focus
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ruminative self-focus
Number of subjects: 40
Study: 19668016

Group type: EXPERIMENTAL
Intervention: senofilcon A lenses
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: LIPCOF, NIBUT, and OSDI
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: LIPCOF Sum plus NIBUT and OSDI
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: LWE
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Limbal hyperaemia
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: NIBUT
Number of subjects: 33
Study: 17667723

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG) 3 x 10 colony-forming units, twice daily for 4 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo, twice daily for 4 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 15363567

Group type: EXPERIMENTAL
Intervention: Transurethral ethanol ablation of the prostate (TEAP) using ProstaJect device, average ethanol injected 14 ml.
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Transurethral ethanol ablation of the prostate (TEAP)
Number of subjects: 115
Study: 11442862

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40
Study: 9740115

Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 7979340

Group type: EXPERIMENTAL
Intervention: 40 g of sucrose
Number of subjects: 52

Group type: COMPARATOR
Intervention: 4.34 g of saccharin
Number of subjects: 52
Study: 2806714

Group type: EXPERIMENTAL
Intervention: Test formulation of atenolol (100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference formulation of atenolol (100 mg)
Number of subjects: 0
Study: 241272

Group type: EXPERIMENTAL
Intervention: Alfatesine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pentothal
Number of subjects: 0
Study: 31665001

Group type: EXPERIMENTAL
Intervention: Self-management education through weblogs
Number of subjects: 98
Study: 27346074

Group type: EXPERIMENTAL
Intervention: Solifenacin (5 mg orally) on the day before, the day, and the day after TUR-BT
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard care (Control group)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Solifenacin (5 mg orally)
Number of subjects: 148
Study: 26327130

Group type: EXPERIMENTAL
Intervention: AJM300 (960 mg)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 23439259

Group type: EXPERIMENTAL
Intervention: MK-7009 (vaniprevir) + PegIFN + ribavirin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo + PegIFN + ribavirin
Number of subjects: 40
Study: 20947097

Group type: EXPERIMENTAL
Intervention: Lung lavage with dilute bovine surfactant (two 15‐mL/kg aliquots)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Lung lavage with dilute bovine surfactant
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Lung lavage with dilute surfactant
Number of subjects: 65
Study: 18507545

Group type: EXPERIMENTAL
Intervention: 8F leads
Number of subjects: 714

Group type: COMPARATOR
Intervention: 7F leads
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 714
Study: 16892434

Group type: EXPERIMENTAL
Intervention: Symbiot ePTFE covered stent
Number of subjects: 400

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 400
Study: 14570785

Group type: EXPERIMENTAL
Intervention: Alfentanil 30 microg kg(‐1)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg kg(‐1)
Number of subjects: 13
Study: 10971827

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy for 16 or 32 weeks
Number of subjects: 162

Group type: COMPARATOR
Intervention: No further treatment after 16 weeks
Number of subjects: 162

Group type: COMPARATOR
Intervention: Prolonged treatment for another 16 weeks
Number of subjects: 162
Study: 8627059

Group type: EXPERIMENTAL
Intervention: High-dose didanosine (ddI) 375 mg twice daily
Number of subjects: 73

Group type: COMPARATOR
Intervention: Low-dose didanosine (ddI) 100 mg twice daily
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) monotherapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Zidovudine monotherapy
Number of subjects: 73
Study: 1307608

Group type: EXPERIMENTAL
Intervention: DNA-probe assay using the Gen-probe kit
Number of subjects: 32

Group type: COMPARATOR
Intervention: Serological tests (complement fixation and passive hemagglutination tests)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: DNA-probe assay
Number of subjects: 32
Study: 6486240

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Coordinated team of allied health professionals (AHPs) evaluated regularly
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison Group (CG) - AHPs seen only upon referral
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Grip strength improvement
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison Group (CG) - Grip strength decrease
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Hand range of motion
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Finger flexion deformities
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Positive attitudes
Number of subjects: 23
Study: 31168999

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HHA) + Platelet Rich Plasma (PRP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HHA)
Number of subjects: 60
Study: 29420536

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate hydration (250 ml 1.4%)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Saline hydration (1000 ml 0.9%)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate hydration
Number of subjects: 333

Group type: COMPARATOR
Intervention: Saline hydration
Number of subjects: 333
Study: 27352285

Group type: EXPERIMENTAL
Intervention: Alexis(®) O C‐Section Retractor
Number of subjects: 198

Group type: COMPARATOR
Intervention: Collins self‐retaining metal retractor
Number of subjects: 198
Study: 24797030

Group type: EXPERIMENTAL
Intervention: Anodal cerebellar transcranial direct current stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study: 22613903

Group type: EXPERIMENTAL
Intervention: Narrow band imaging (NBI)
Number of subjects: 112

Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 112
Study: 20722643

Group type: EXPERIMENTAL
Intervention: Double-dose misoprostol 25 microg
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Dinoprostone 3 mg
Number of subjects: 171

Group type: COMPARATOR
Intervention: Single-dose misoprostol
Number of subjects: 171
Study: 18596716

Group type: EXPERIMENTAL
Intervention: Early cord clamping (30 s)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Late cord clamping (3 min)
Number of subjects: 64
Study: 16099292

Group type: EXPERIMENTAL
Intervention: Roflumilast 250 microg
Number of subjects: 1411

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg
Number of subjects: 1411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1411
Study: 11912072

Group type: EXPERIMENTAL
Intervention: MMT (Methadone Maintenance Treatment)
Number of subjects: 359

Group type: COMPARATOR
Intervention: N-MMT (Non-Methadone Maintenance Treatment)
Number of subjects: 359
Study: 10522982

Group type: EXPERIMENTAL
Intervention: Androderm testosterone transdermal system (TTD) - two 2.5-mg systems applied nightly
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intramuscular testosterone enanthate (i.m.) - 200 mg injected every 2 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 66
Study: 8706192

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms x kg(‐1), n = 25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg (n = 25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Droperidol 2.5 mg (n = 25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline, n = 25)
Number of subjects: 100
Study: 1703946

Group type: EXPERIMENTAL
Intervention: Simultaneous stimulation of bilateral median nerves
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simultaneous stimulation of left median and left ulnar nerves
Number of subjects: 12
Study: 7261688

Group type: EXPERIMENTAL
Intervention: Talampicillin (TMP) 325 mg (equivalent to 200 mg ampicillin)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ampicillin (AMP) 500 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study: 31445091

Group type: EXPERIMENTAL
Intervention: vPTA (venous percutaneous transluminal angioplasty)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (vPTA-not)
Number of subjects: 66
Study: 30842057

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0
Study: 28143919

Group type: EXPERIMENTAL
Intervention: Ivacaftor (CFTR potentiator)
Number of subjects: 83
Study: 25911497

Group type: EXPERIMENTAL
Intervention: Neurectomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Neurolysis
Number of subjects: 22
Study: 23791513

Group type: EXPERIMENTAL
Intervention: JNJ‐39220675
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 22211206

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (N=160) with phone contact from a registered nurse and clinical pharmacist, and psychiatrist supervision via video chats.
Number of subjects: 360

Group type: COMPARATOR
Intervention: Usual care (N=200)
Number of subjects: 360
Study: 19890693

Group type: EXPERIMENTAL
Intervention: Local lidocaine injections during ESDs (mean dose 236 mg, mean volume 55.4 ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional normal saline solution injections during ESDs (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Local lidocaine injections during ESDs (LG)
Number of subjects: 20
Study: 17029975

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (AA) 1500mg/day for 2 years
Number of subjects: 222
Study: 15252821

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 56

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 56
Study: 10994156

Group type: EXPERIMENTAL
Intervention: Betaine glucuronate combined with diethanolamine glucuronate and nicotinamide ascorbate (Ietepar)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 9305556

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 g in 500 ml NSaline)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (NSaline)
Number of subjects: 41
Study: 8285082

Group type: EXPERIMENTAL
Intervention: Antacid containing aluminum hydroxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3543246

Group type: EXPERIMENTAL
Intervention: 5-FU (1,000 mg/m2 days 1 through 4) with bolus FA (200 mg/m2 days 1 through 4) - infusion arm
Number of subjects: 125

Group type: COMPARATOR
Intervention: 5-FU (325 mg/m2 days 1 through 5) with bolus FA (200 mg/m2 days 1 through 5) - bolus arm
Number of subjects: 125
Study: 30946265

Group type: EXPERIMENTAL
Intervention: Known load 1RM trial
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unknown load 1RM trial
Number of subjects: 20
Study: 29400070

Group type: EXPERIMENTAL
Intervention: Accelerometer-based feedback
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (no accelerometer-based feedback)
Number of subjects: 55
Study: 26825109

Group type: EXPERIMENTAL
Intervention: 12-month Balance Training Programme
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention beyond regular osteoporosis treatment)
Number of subjects: 100
Study: 25809854

Group type: EXPERIMENTAL
Intervention: High dairy diet (primarily low-fat dairy)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High red meat diet (lean red meat)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control diet (neither red meat nor dairy)
Number of subjects: 47